Skip to content

neurodegenerative gene therapy

Klotho Neurosciences Stock Surges 787.8% on Gene Therapy Breakthrough Speculation

Klotho Neurosciences has experienced an unprecedented stock surge of 787.8% following market speculation about a potential gene therapy breakthrough for neurodegenerative diseases including Alzheimer’s and Parkinson’s. The dramatic price movement was fueled by intense retail investor activity and market optimism,… Read More »Klotho Neurosciences Stock Surges 787.8% on Gene Therapy Breakthrough Speculation